Transition Therapeutics shareholders approve acquisition by OPKO Health
OPKO Health announced that shareholders of Transition Therapeutics voted to approve the previously announced agreement under which OPKO Health will acquire Transition Therapeutics. The acquisition is subject to final approval of the Ontario Superior Court Justice. August 26, 2016